Subscribe to Newsletter

Refine results:

Refine results

White Papers

Results 1–10 of 123

Nitrosamines Risk Mitigation: The critical role of excipients and supplier qualification

| Contributed by DFE Pharma GmbH & Co. KG

The evaluation of nitrosamines in drug products has become a big challenge for many formulators in the pharmaceutical industry.

Ploughshare® Mixer for batch operation in pharmaceutical production: well-established all-rounder

| Contributed by Lodige

The advantages of a horizontal Ploughshare® Mixer used lie in the short mixing time with the highest mixing precision in the 1:100,000 range

Accelerate Your Cell Line Development Process for Commercial Production

| Contributed by Sartorius

Biopharmaceutical drug products, or biologics, are fast becoming an essential branch of the healthcare industry.

Direct-to-Patient (DtP) Clinical Trials – Using RTSM Systems to Overcome Supply Challenges

| Contributed by 4G Clinical

Leveraging Modern Randomisation and Trial Supply Management (RTSM) Systems to Overcome Supply Challenges with DtP Trials

Development of a universal preparative AEX method to purify oligonucleotides

| Contributed by Tosoh

Oligonucleotide-based therapeutics have been investigated over the last decades and their promise as a new drug modality is now being realized.

Effective Removal of mAb Aggregate Using Ca++Pure-HA® Media with Potassium Salts

| Contributed by Tosoh

Discover the better performance of Ca++Pure-HA

Highly sensitive and robust LC-MS/MS solution for quantitation of nitrosamine impurities in metformin drug products

| Contributed by Thermo Fisher Scientific

From this app note, discover a robust and sensitive method for the quantitation of nitrosamine impurities in metformin drug products

Accelerate recruitment with a decentralized clinical trial strategy

| Contributed by Thermo Fisher Scientific

To execute decentralized research strategies, sponsors are turning to an integrated supply chain solution known as Direct-to-Patient Services.

Beyond Heat – Practical Requirements of a Microwave Synthesizer

| Contributed by Biotage

This whitepaper discusses the utilisation of microwave technology in synthesis.

Optimizing Downstream Processing for an Inactivated Rabies Vaccine

| Contributed by MilliporeSigma

While rabies is a preventable and curable disease, it continues to have an impact on human and animal health in developing countries.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine